Abstract:Objective To investigate the clinical value of uterine artery ultrasound combined with serum transforming growth factor β1 (TGF-β1) and insulin-like growth factors (IGF-1) in predicting early preeclampsia. Methods Sixty pre-eclampsia pregnant women and 60 normal pregnant women admitted to our hospital from March 2015 to March 2018 were enrolled as study group and control group. Uterine artery ultrasonography was performed in all patients, serum TGF-β1 and IGF-1 expression levels were measured by enzyme-linked immunosorbent assay (ELISA), and the logistic regression model was combined with the receiver operating characteristic curve (ROC) to evaluate the clinical value of combined detection for the early diagnosis of early onset eclampsia. Results The blood pressure and PI values of the study group were significantly higher than those of the control group (P?0.05). The serum TGF-β1 expression level of the study group was significantly higher than that of the control group, while IGF-1 was significantly lower (P?0.05). The area under the ROC curve (0.887) detected by uterine artery ultrasound combined with serum TGF-β1 and IGF-1 was significantly higher than that of each index (0.765, 0.733 and 0.675), and the difference was statistically significant (Z?=?2.314, P?=?0.021). Conclusion Uterine artery ultrasound combined with serum TGF-β1 and IGF-1 can improve the sensitivity and specificity of diagnosis of early onset eclampsia, and it has potential application value for early diagnosis of early onset eclampsia.